Assessment and management of chronic hepatitis B.
Institute of Hepatology, University College London, UCL Hospitals. n.naoumov@ucl.ac.uk
Nikolai V
NV
Naoumov
D000410:Alanine Transaminase / Q000097:blood; D000998:Antiviral Agents / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D018450:Disease Progression; D014943:Global Health; D006513:Hepatitis B e Antigens / Q000097:blood; D019694:Hepatitis B, Chronic / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D006113:United Kingdom; D000509:alpha-Fetoproteins / Q000378:metabolism
D000998:Antiviral Agents; D015415:Biomarkers; D006513:Hepatitis B e Antigens; D018894:Reverse Transcriptase Inhibitors; D000509:alpha-Fetoproteins; D000410:Alanine Transaminase